Genotype-first analysis of a generally healthy population cohort supports genetic testing for diagnosis of hereditary angioedema of unknown cause
Abstract Background Hereditary angioedema (HAE) is a potentially life-threatening group of conditions that is often underdiagnosed or misdiagnosed. As HAE is typically diagnosed by detecting C1 inhibitor deficiency, there is a critical need for methods that can identify affected individuals with nor...
Main Authors: | Dale L. Bodian, Thierry Vilboux, Natalie S. Hauser |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Allergy, Asthma & Clinical Immunology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13223-019-0346-1 |
Similar Items
-
Hereditary angioedema
by: Helen Lesser, et al.
Published: (2021-07-01) -
Screening for Plasminogen Mutations in Hereditary Angioedema Patients
by: Henriette Farkas, et al.
Published: (2021-03-01) -
Angioedema and Fatty Acids
by: Akane Wada, et al.
Published: (2021-08-01) -
Review of the Manitoba cohort of patients with hereditary angioedema with normal C1 inhibitor
by: Lundy McKibbin, et al.
Published: (2019-11-01) -
A patient with hereditary angioedema and systemic lupus erythematosus:
Coincidence or coexistence?
by: Gokhan Aytekin, et al.
Published: (2020-06-01)